Trial Profile
IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 15 Sep 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 15 Sep 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2025.
- 25 Oct 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.